GAIL ELIZABETH TOMLINSON

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi Genetics and epigenetics of hepatoblastoma
    Gail E Tomlinson
    Department of Pediatrics, Greehey Children s Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    Pediatr Blood Cancer 59:785-92. 2012
  2. ncbi Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
  3. ncbi Cytogenetics of hepatoblastoma
    Gail E Tomlinson
    University of Texas Health Science Center at San Antonio, Greehey Children s Cancer Research Institute, San Antonio, Texas 78229, USA
    Front Biosci (Elite Ed) 4:1287-92. 2012
  4. ncbi Activating mutation in MET oncogene in familial colorectal cancer
    Deborah W Neklason
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    BMC Cancer 11:424. 2011
  5. ncbi Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children
    Ryan M Swinney
    Department of Pediatrics and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Cancer Epidemiol Biomarkers Prev 20:1537-42. 2011

Research Grants

  1. Serum Markers of Angiogenesis in von Hippel-Lindau Dise*
    Gail Tomlinson; Fiscal Year: 2005

Collaborators

  • Anna Marie Mulligan
  • Deborah W Neklason
  • Ryan M Swinney
  • Christian F Singer
  • Marie Stenmark-Askmalm
  • Rosa B Barkardottir
  • Jenny Gross
  • Mark Robson
  • Mark Sherman
  • Maroulio Pertesi
  • Georgia Chenevix-Trench
  • Pascaline Berthet
  • Siranoush Manoukian
  • Barbara Pasini
  • Martine Dumont
  • Esther M John
  • Olufunmilayo Olopade
  • Yuan Chun Ding
  • Ute Hamann
  • von Anna Wachenfeldt
  • Wolfram Heinritz
  • Kenneth Offit
  • Torben A Kruse
  • Susan J Ramus
  • Laura Papi
  • Thomas vO Hansen
  • Fergus J Couch
  • Mark H Greene
  • Jeffrey N Weitzel
  • Daniel Barrowdale
  • Julian Barwell
  • Hilmi Ozcelik
  • Julian Adlard
  • Isabelle Mortemousque
  • Sylvie Mazoyer
  • Vernon S Pankratz
  • David Goldgar
  • Michel Longy
  • Debra Frost
  • Marcel R Nelen
  • Xianshu Wang
  • Anneliese Fink-Retter
  • Daphne Gschwantler-Kaulich
  • Susan L Neuhausen
  • Csilla Szabo
  • Paolo Radice
  • Irene L Andrulis
  • Dieter Niederacher
  • Christoph Engel
  • Randall W Burt
  • Hanne E J Meijers-Heijboer
  • Alfons Meindl
  • Nicolas Sevenet
  • Stephen Fox
  • Uffe Birk Jensen
  • Norbert Arnold
  • Helen Gregory
  • Madeleine M A Tilanus-Linthorst
  • Wendy Chung
  • Trinidad Caldes
  • Andrew Lee
  • Caroline Seynaeve
  • Noah Kauff
  • Karin Kast
  • Gordon Glendon
  • Daniela Zaffaroni
  • Barbara Wappenschmidt
  • Silvia Tognazzo
  • Caroline Kientz
  • Bernardo Bonanni
  • Joellen M Schildkraut
  • Dieter Schäfer
  • Per Karlsson
  • Francois Cornelis
  • Olga M Sinilnikova
  • Alan Donaldson
  • Penny Soucy
  • Tina T L Chen
  • Heli Nevanlinna
  • Alessandra Viel
  • Naomi J Winick
  • Alexander R Miller
  • Huw Dorkins
  • Rosemarie Davidson
  • Paul D P Pharoah
  • Javier Benitez
  • Melanie Leone
  • Amanda E Toland
  • Raymonda Varon-Mateeva
  • Diana Eccles

Detail Information

Publications5

  1. ncbi Genetics and epigenetics of hepatoblastoma
    Gail E Tomlinson
    Department of Pediatrics, Greehey Children s Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    Pediatr Blood Cancer 59:785-92. 2012
    ..Tumor-specific signatures based on transcriptional or epigenetic alterations will be reviewed that might be used in the future to better diagnose and subtype the disease as well as predict prognosis and response to therapy...
  2. ncbi Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
    ..It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumour...
  3. ncbi Cytogenetics of hepatoblastoma
    Gail E Tomlinson
    University of Texas Health Science Center at San Antonio, Greehey Children s Cancer Research Institute, San Antonio, Texas 78229, USA
    Front Biosci (Elite Ed) 4:1287-92. 2012
    ..A rare sub-type of hepatoblastoma, known as the small cell undifferentiated variant, is associated with deletion or translocation of 22q, the locus of the rhabdoid tumor gene, SMARCB1...
  4. ncbi Activating mutation in MET oncogene in familial colorectal cancer
    Deborah W Neklason
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    BMC Cancer 11:424. 2011
    ..Familial colorectal cancer has been linked to chromosome 7q31 by multiple affected relative pair studies. The MET proto-oncogene which resides in this chromosomal region is considered a candidate for genetic susceptibility...
  5. ncbi Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children
    Ryan M Swinney
    Department of Pediatrics and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Cancer Epidemiol Biomarkers Prev 20:1537-42. 2011
    ..Previous reports have shown an association between CYP1A1 variants and ALL...

Research Grants2

  1. Serum Markers of Angiogenesis in von Hippel-Lindau Dise*
    Gail Tomlinson; Fiscal Year: 2005
    ..The establishment of a VHL registry in North Texas will also place us in an excellent position to develop clinical protocols aimed towards early detection of lesions in VHL patients. ..